CoChat

Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations

Open access
Williams, David M, Jones, Hannah, Stephens, Jeffrey W · 2022 · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.

Abstract

Previous guidelines for the treatment of people with type 2 diabetes mellitus (T2D) have relied heavily upon rigid algorithms for the sequential addition of pharmacotherapies to achieve target glycemic control. More recent guidelines advocate a personalized approach for diabetes treatment, to improve patient satisfaction, quality of life, medication adherence and overall health outcomes. Clinicians should work with patients to develop personalized goals for their treatment, including targeted glycemic control, weight management, prevention and treatment of associated comorbidities and avoidance of complications such as hypoglycemia. Factors that affect the intensity of treatment and choice of pharmacotherapy should include medical and patient influences. Medical considerations include the diabetes phenotype, biomarkers including genetic tests, and the presence of comorbidities such as cardiovascular, renal, or hepatic disease. Patient factors include their treatment preference, age and life expectancy, diabetes duration, hypoglycemia fear and unawareness, psychological and social circumstances. The use of a personalized approach in the management of people with T2D can reduce the cost and failure associated with the algorithmic "one-size-fits-all" approach, to anticipate disease progression, improve the response to diabetes pharmacotherapy and reduce the incidence of diabetes-associated complications. Ultimately, the use of personalized medicine in people with T2D should improve medication adherence, patient satisfaction and quality of life to reduce diabetes distress and improve physical health outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/dmso.s331654

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Personalized diabetes care. This figure summarizes the key considerations that are needed when contemplating the choice of diabetes pharmacotherapy for a patient with T2D.
Figure 1 Personalized diabetes care. This figure summarizes the key considerations that are needed when contemplating the choice of diabetes pharmacotherapy for a patient with T2D.CC BY-NC · PubMed Central
Figure 2 Therapeutic strategies for T2DM during time. This figure summarizes the key therapeutic strategies employed for people with T2D at different stages.
Figure 2 Therapeutic strategies for T2DM during time. This figure summarizes the key therapeutic strategies employed for people with T2D at different stages.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 176

Metadata

Authors
Williams, D. M., Jones, H., & Stephens, J. W.
Affiliations
Swansea Bay University Health Board (GB)
Corresponding author
Williams, David M
Venue
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Published
2022-02
Volume
Volume 15
Pages
281-295
ISSN
1178-7007 (ISSN-L)
OpenAlex
W4210447482
Cited by
121
References
107
Citations by year
2026: 19 · 2025: 41 · 2024: 31 · 2023: 21 · 2022: 9
FWCI
3.63
Type
journal article
Language
en
Open access
Locations
  • Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 2 diabetes, personalized medicine, glycemic control, diabetes pharmacotherapy, diabetes phenotypes, genetic biomarkers, comorbidities, hypoglycemia, medication adherence, patient satisfaction, quality of life, diabetes distress, weight management, treatment goals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.